Trial
NCT05813288
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Areteia Therapeutics
Collaborators
—
Condition
Eosinophilic Asthma
Intervention
Dexpramipexole Dihydrochloride
Why stopped
Program stopped due to the benefit risk profile no longer supports further development in the intended patient population.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-15